Questions about OTC or prescription medications while pregnant or nursing?
Call our experts.
Monday – Friday, 8am – 5pm CT
1 (806) 352-2519
Pain is the most common reason that patients seek medical attention. Pain is a symptom with an extremely broad differential diagnosis. Effective treatments are based on proper diagnosis. The source, severity, and the cause of the pain need also be considered. There are several analgesics that can be used for a variety of pain syndromes.
In the USA and many other countries, the predominant enterohemorrhagic E. coli subtype associated with disease is E. coli O157:H7. Recently, a large number of cases of antibiotic-resistant E. coli O104 have been reported in Germany, some in breastfeeding mothers. This particular species is known to secrete Shiga toxins and to produce potentially severe renal disease in humans.
Topical teething products containing benzocaine have been formulated to soothe the pain of teething in infants and children. The Food and Drug Administration (FDA) has recently reported that the use of benzocaine may increase the risk of a serious medical condition called methemoglobinemia.
Potassium iodide was approved by the Food and Drug Administration(FDA) in 1982 for thyroid protection from radioactive iodine accidents. Of the many radioactive elements released by nuclear accidents, radioactive Iodine-131 is a major component and a huge risk factor for humans.
The Food and Drug Administration has announced that use of Topiramate (Topamax) by pregnant women can result in birth defects such as cleft lip or palate. Topiramate is an anti-convulsant medication used in the treatment of seizure disorder and for the prevention of migraines.
Breastfeeding is currently recommended by the American Academy of Pediatrics as the exclusive source of nutrition for feeding young infants for the first six months of life. Data suggests that not only are there psychological benefits from its use, but nutritional, gastrointestinal, and host defense benefits as well.
About the InfantRisk Center Team
Thomas Hale, Ph.D., R.Ph., is a professor of pediatrics and associate dean of research at Texas Tech University Health Sciences Center and acting executive director of the InfantRisk Center.
Hale is considered one of the foremost expert in the field of perinatal pharmacology and the use of medications by pregnant and breastfeeding mothers.
The vision of the InfantRisk Center is to create a new body of drug information concerning the safety of medications and their use during pregnancy and lactation. Additionally, the center will expand, enhance and disseminate knowledge regarding the use of medications and other environmental chemicals by pregnant and breastfeeding women worldwide.
Dr. Baker graduated from the University of Texas Southwestern and completed her residency training at Parkland Health and Hospital System in Dallas, TX. She is Board Certified by the American Board of Obstetrics and Gynecology and is a Fellow of the American College of Obstetricians and Gynecologists.
Dr. Baker has a combined private and academic OB/GYN practice with the University Physicians at Texas Tech Health Sciences Center in Amarillo. She is interested in teen pregnancy, postpartum depression, and promoting preventive medicine for the women of the Texas Panhandle, as well as Resident and Student education and serves as the Residency Director.